2025–2026 Regular Session · House of Representatives bill

HB 2041

An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing, for duties of department and for blood lead assessment and testing coverage.

In committee Last action November 17, 2025: Referred to Children & Youth

Official bill page and text: palegis.us

Sponsors 36

Prime sponsor

Shelby Labs

Cosponsors (35)

Abigail Salisbury, Ben Waxman, Benjamin Sanchez, Dan Frankel, Dan Williams, Dave Madsen, Ed Neilson, Eddie Pashinski, Elizabeth Fiedler, G. Roni Green, Gina Curry, Greg Scott, Heather Boyd, Ismail Smith-Wade-El, Jeanne Mcneill, Jim Prokopiak, Joe Ciresi, Joe Hogan, Jose Giral, Joseph Hohenstein, Kristin Marcell, Lindsay Powell, Lisa Borowski, Liz Hanbidge, Mark Gillen, Mary Jo Daley, Marylouise Isaacson, Mike Armanini, Nancy Guenst, Natalie Mihalek, Nikki Rivera, R. Lee James, Rick Krajewski, Tarik Khan, Tim Briggs

Status

In committee as of November 17, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
November 17, 2025	House	Referred to Children & Youth

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.